论文部分内容阅读
目的 :评价药物涂层冠状动脉内支架的早期疗效。方法 :2 0 0 2年 9月～ 2 0 0 3年 4月 10 2例冠心病患者接受药物涂层冠状动脉内支架术治疗 (14 1枚 ,药物支架组 ) ,随机选择同期 10 2例接受普通、非药物涂层支架治疗 (15 8枚 ,裸支架组 ) ,比较两组支架置入情况及早期临床事件发生率。结果 :两组手术成功率相似 (10 0 %∶99.0 % ,P >0 .0 5 )。平均随访 (4 .9± 3.3)个月 ,随访率 87.2 % ,药物支架组心绞痛复发率显著低于裸支架组(7.8%∶2 3.5 % ,P <0 .0 1)。结论 :冠心病患者应用药物涂层支架治疗早期临床效果优于普通标准支架
OBJECTIVE: To evaluate the early effect of drug-coated coronary stents. METHODS: Between September 2002 and April 2003, 102 patients with coronary heart disease were treated with drug-coated coronary stent (14 1, drug-eluting stents), and 102 patients were randomly selected during the same period The common and non-drug-coated stent treatment (15 8, bare stent group), stent placement and early clinical events were compared between the two groups. Results: The success rates of the two groups were similar (100%: 99.0%, P> 0.05). The average follow-up was (4.9 ± 3.3) months. The follow-up rate was 87.2%. The recurrence rate of angina pectoris group was significantly lower than that of the bare stent group (7.8% vs2.35%, P <0.01). Conclusion: The early clinical effect of drug-coated stent in patients with coronary heart disease is better than that of common standard stent